Clinical Trials in Washington

Showing 3921-3940 of 9,462 trials

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes

NCT05505136

To determine the associations among biometric data and previously reported medication changes in the original MAPS study

Cardiac Arrhythmia

Zoll Medical Corporation62 participantsStarted Aug 2022

Ocala, Florida, United States • Saint Augustine, Florida, United States • Jackson, Mississippi, United States +5 more locations

COMPLETEDNA42 miles

Emergency Department Longitudinal Integrated Care

NCT03699085

The overarching goal of this investigation is to develop and determine the feasibility of a multi-component intervention adapted from a collaborative care framework initiated in the ED for patients at risk for opioid use disorder. This study will provide important feasibility information for future studies of ED-LINC. The collaborative care intervention (ED-LINC) will be supported by a novel Emergency Departement (ED) health information exchange platform.

Opioid-use DisorderEmergency Department

University of Washington40 participantsStarted Dec 2018

Seattle, Washington, United States

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes

Emergency Department Longitudinal Integrated Care

Find Trials by Condition in Washington

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

Treatment of Moderate to Severe Lateral Canthal Lines

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

Methylphenidate in Treating Patients With Melanoma

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer